JG
Jason Gerberry B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Amphastar Pharmaceuticals
AMPH
$1.36B
| $29.19 | $32 |
10%
upside
| Neutral | 9 days ago |
|
2
Immunovant
IMVT
$2.81B
| $16.12 | $30 |
86%
upside
| Buy | 23 days ago |
|
3
Biohaven
BHVN
$1.7B
| $16.07 | $49 |
205%
upside
| Buy | 23 days ago |
|
4
Axsome Therapeutics
AXSM
$6.21B
| $124.41 | $176 |
41%
upside
| Buy | 1 month ago |
|
5
ProKidney
PROK
$310M
| $2.30 | $1 |
57%
downside
| Underperform | 2 months ago |
|
6
Liquidia Corp
LQDA
$2.48B
| $28.84 | $23 |
20%
downside
| Buy | 2 months ago |
|
7
Exelixis
EXEL
$10.1B
| $37.38 | $46 |
23%
upside
| Neutral | 3 months ago |
|
8
Teva Pharmaceuticals
TEVA
$21.2B
| $18.48 | $22 |
19%
upside
| Buy | 3 months ago |
|
9
Vaxcyte
PCVX
$4.17B
| $32.15 | $137 |
326%
upside
| Buy | 5 months ago |
|
10
Viatris
VTRS
$12B
| $10.33 | $10 |
3%
downside
| Underperform | 6 months ago |
|
11
Catalyst Pharmaceutical
CPRX
$2.42B
| $19.80 | $30 |
52%
upside
| Buy | 7 months ago |
|
12
Arcellx
ACLX
$4B
| $72.16 | $100 |
39%
upside
| Buy | 10 months ago |
|
13
Relay Therapeutics
RLAY
$690M
| $4 | $24 |
500%
upside
| Buy | 11 months ago |
|
14
Ionis Pharmaceuticals
IONS
$9.46B
| $59.35 | $68 |
15%
upside
| Buy | 1 year ago |
|
15
Oculis Holding
OCS
$898M
| $17.16 | $20 |
17%
upside
| Buy | 1 year ago |
|
16
Galapagos
GLPG
$2.1B
| $31.91 | $31 |
3%
downside
| Underperform | 1 year ago |
|
17
Alkermes
ALKS
$4.77B
| $28.92 | $29 |
0%
upside
| Neutral | 1 year ago |
|
18
Arrowhead Research
ARWR
$3.87B
| $28 | $37 |
32%
upside
| Buy | 1 year ago |
|
19
Xenon Pharmaceuticals
XENE
$2.98B
| $38.64 | $56 |
45%
upside
| Buy | 1 year ago |
|
20
Harmony Biosciences
HRMY
$2.09B
| $36.30 | $30 |
17%
downside
| Underperform | 1 year ago |
|
21
Jazz Pharmaceuticals
JAZZ
$7.77B
| $128.02 | $217 |
70%
upside
| Buy | 2 years ago |
|
22
Eli Lilly
LLY
$666B
| $742.91 | $500 |
33%
downside
| Buy | 2 years ago |
|
23
Organon & Co
OGN
$2.52B
| $9.68 | $25 |
158%
upside
| Underperform | 2 years ago |
|
24
Bausch Health
BHC
$2.67B
| $7.21 | $27 |
274%
upside
| Underperform | 4 years ago |
|
25
AbbVie
ABBV
$376B
| $213 | $95 |
55%
downside
| Neutral | 5 years ago |
|